New drug switch for young transplant patients shows promise
Disease control
Completed
This study involved 81 children who had received an organ transplant (like kidney, liver, or heart) and were taking a standard anti-rejection drug called Prograf. Researchers wanted to see if switching to a longer-acting version called Advagraf was safe and worked just as well. T…
Phase: PHASE2 • Sponsor: Astellas Pharma Europe Ltd. • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC